Method of treatment
OwnerJoanne Bright, Nick Harrington +2inventors
InventorsJoanne Bright, Nick Harrington, Naheed Mirza, Kelly Stanhope
Life of this patent
Estimating the term…
Abstract
The use of [R-(Z)]-α-(methoxyimino)-α-(1-azabicyclo[2.2.2]oct-3-yl)acetonitrile or a pharmaceutically acceptable salt thereof for the treatment of anxiety.
Claims7
The use of [R-(Z)]-α-(methoxyimino)-α-(1-azabicyclo[2.2.2]oct-3-yl)acetonitrile or a pharmaceutically acceptable salt thereof for the treatment of anxiety.
A method for the treatment of anxiety comprising administering to the patient an effective, non-toxic amount of of [R-(Z)]-α-(methoxyimino)-α-(1-azabicyclo[2.2.2]oct-3-yl)acetonitrile or a pharmaceutically acceptable salt thereof.
A pharmaceutical composition, which comprises [R-(Z)]-α-(methoxyimino)-α-(1-azabicyclo[2.2.2]oct-3-yl)acetonitrile or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier for use in the treatment of anxiety.
A pharmaceutical composition, for the treatment of anxiety in patients other than those with Alzheimers's Disease
A use, method or composition according to any preceding claim wherein the pharmaceutically acceptable salt is the monohydrochloride.
Dependencies are inferred from the claim text.